Bright Green Corporation (BGXX)
USD 0.04
(0.0%)
USD 0.04
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 8.25 Million USD | -59.02% |
| 2022 | 27.31 Million USD | 996.72% |
| 2021 | 2.49 Million USD | -15.55% |
| 2020 | 2.94 Million USD | 761.5% |
| 2019 | 342.3 Thousand USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 1.37 Million USD | -12.11% |
| 2024 Q1 | 1.73 Million USD | 17.09% |
| 2023 Q3 | 2.12 Million USD | -29.0% |
| 2023 FY | 11.19 Million USD | -59.02% |
| 2023 Q4 | 1.48 Million USD | -30.17% |
| 2023 Q1 | 2.61 Million USD | 60.34% |
| 2023 Q2 | 2.98 Million USD | 14.31% |
| 2022 Q2 | 12.88 Million USD | 1673.69% |
| 2022 Q1 | 726.34 Thousand USD | -21.16% |
| 2022 FY | 27.31 Million USD | 996.72% |
| 2022 Q4 | 1.62 Million USD | -71.79% |
| 2022 Q3 | 5.77 Million USD | -55.16% |
| 2021 Q4 | 921.29 Thousand USD | 46.65% |
| 2021 FY | 2.49 Million USD | -15.55% |
| 2021 Q3 | 628.21 Thousand USD | 45.6% |
| 2021 Q2 | 431.47 Thousand USD | -15.32% |
| 2021 Q1 | 509.54 Thousand USD | -26.57% |
| 2020 FY | 2.94 Million USD | 761.5% |
| 2020 Q4 | 693.93 Thousand USD | -43.7% |
| 2020 Q3 | 1.23 Million USD | 101.29% |
| 2020 Q2 | 612.31 Thousand USD | 8.73% |
| 2020 Q1 | 563.15 Thousand USD | 0.0% |
| 2019 FY | 342.3 Thousand USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Alpha Teknova, Inc. | 45.85 Million USD | 82.004% |
| ANI Pharmaceuticals, Inc. | 195.98 Million USD | 95.789% |
| Aquestive Therapeutics, Inc. | 44.85 Million USD | 81.601% |
| Collegium Pharmaceutical, Inc. | 159.2 Million USD | 94.816% |
| Cosmos Health Inc. | 26.18 Million USD | 68.477% |
| Journey Medical Corporation | 54.59 Million USD | 84.883% |
| Embecta Corp. | 528.4 Million USD | 98.438% |
| Esperion Therapeutics, Inc. | 271.89 Million USD | 96.965% |
| Dynavax Technologies Corporation | 219.14 Million USD | 96.234% |
| Intra-Cellular Therapies, Inc. | 590 Million USD | 98.601% |
| Pacira BioSciences, Inc. | 326.37 Million USD | 97.471% |
| PainReform Ltd. | 9.58 Million USD | 13.889% |
| Sunshine Biopharma, Inc. | 13.12 Million USD | 37.118% |
| Sunshine Biopharma, Inc. | 13.12 Million USD | 37.118% |
| SCYNEXIS, Inc. | 51.84 Million USD | 84.083% |
| Safety Shot Inc | 12.1 Million USD | 31.849% |
| China SXT Pharmaceuticals, Inc. | 3.06 Million USD | -168.894% |
| Procaps Group, S.A. | 199.47 Million USD | 95.863% |
| Theratechnologies Inc. | 72.75 Million USD | 88.657% |
| Harrow Health, Inc. | 89.97 Million USD | 90.827% |
| Sonoma Pharmaceuticals, Inc. | 9.44 Million USD | 12.631% |
| Biofrontera Inc. | 39.95 Million USD | 79.347% |
| DURECT Corporation | 43.71 Million USD | 81.121% |
| Supernus Pharmaceuticals, Inc. | 529.01 Million USD | 98.44% |
| Cronos Group Inc. | 96.7 Million USD | 91.466% |
| OptiNose, Inc. | 85.1 Million USD | 90.302% |
| Ironwood Pharmaceuticals, Inc. | 232.12 Million USD | 96.445% |
| Kala Pharmaceuticals, Inc. | 39.15 Million USD | 78.921% |
| RedHill Biopharma Ltd. | -9.56 Million USD | 186.318% |
| Organogenesis Holdings Inc. | 314.13 Million USD | 97.373% |
| Guardion Health Sciences, Inc. | 9.73 Million USD | 15.188% |
| Cumberland Pharmaceuticals Inc. | 43.04 Million USD | 80.825% |
| Radius Health, Inc. | 265.92 Million USD | 96.897% |
| Universe Pharmaceuticals INC | 13.84 Million USD | 40.378% |
| ProPhase Labs, Inc. | 37.85 Million USD | 78.197% |
| Phibro Animal Health Corporation | 260.29 Million USD | 96.829% |
| Procaps Group S.A. | 187.24 Million USD | 95.592% |
| Alvotech | 285.43 Million USD | 97.109% |
| TherapeuticsMD, Inc. | 9.82 Million USD | 16.001% |
| Viatris Inc. | 5.96 Billion USD | 99.862% |
| Rockwell Medical, Inc. | 15.37 Million USD | 46.319% |
| Aytu BioPharma, Inc. | 59.84 Million USD | 86.208% |
| SIGA Technologies, Inc. | 22.04 Million USD | 62.56% |
| Tilray Brands, Inc. | 251.35 Million USD | 96.717% |
| Lifecore Biomedical, Inc. | 49.03 Million USD | 83.17% |
| Shineco, Inc. | 17.94 Million USD | 54.018% |
| PetIQ, Inc. | 192.72 Million USD | 95.718% |
| Regencell Bioscience Holdings Limited | 3.99 Million USD | -106.78% |
| Incannex Healthcare Limited | 30.05 Million USD | 72.539% |
| Neurocrine Biosciences, Inc. | 1.59 Billion USD | 99.483% |
| Alimera Sciences, Inc. | 62.64 Million USD | 86.825% |
| Silver Spike Investment Corp. | 762.49 Thousand USD | -982.355% |
| Assertio Holdings, Inc. | 368.58 Million USD | 97.761% |
| Shuttle Pharmaceuticals Holdings, Inc. | 5.88 Million USD | -40.222% |
| Petros Pharmaceuticals, Inc. | 17.8 Million USD | 53.658% |
| Clever Leaves Holdings Inc. | 21.16 Million USD | 61.014% |
| Cyclo Therapeutics, Inc. | 21.04 Million USD | 60.779% |
| Avadel Pharmaceuticals plc | 164.96 Million USD | 94.997% |
| Hempacco Co., Inc. | 7.59 Million USD | -8.641% |
| Talphera, Inc. | 11.99 Million USD | 31.192% |
| Alvotech | 285.43 Million USD | 97.109% |
| Eagle Pharmaceuticals, Inc. | 140.71 Million USD | 94.135% |
| Lantheus Holdings, Inc. | 344.9 Million USD | 97.607% |
| Currenc Group, Inc. | 24 Million USD | 65.616% |
| Kamada Ltd. | 45.42 Million USD | 81.832% |
| Indivior PLC | 911 Million USD | 99.094% |
| Evoke Pharma, Inc. | 12.4 Million USD | 33.496% |
| Flora Growth Corp. | 10.57 Million USD | 21.988% |
| Cyclo Therapeutics, Inc. | 21.04 Million USD | 60.779% |
| Evolus, Inc. | 189.75 Million USD | 95.651% |
| HUTCHMED (China) Limited | 436.23 Million USD | 98.108% |
| Amphastar Pharmaceuticals, Inc. | 154.13 Million USD | 94.646% |
| Akanda Corp. | 3.48 Million USD | -136.913% |